IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455,505 | +10.6% | 10,042 | 0.0% | 0.07% | +11.7% |
| Q2 2023 | $412,023 | +14.8% | 10,042 | 0.0% | 0.06% | +7.1% |
| Q1 2023 | $358,901 | -5.4% | 10,042 | 0.0% | 0.06% | -12.5% |
| Q4 2022 | $379,286 | -14.6% | 10,042 | 0.0% | 0.06% | -25.6% |
| Q3 2022 | $444,000 | +19.4% | 10,042 | 0.0% | 0.09% | +13.2% |
| Q2 2022 | $372,000 | -7.2% | 10,042 | 0.0% | 0.08% | +24.6% |
| Q2 2021 | $401,000 | – | 10,042 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |